Enter your email address
Submit
Write your message
Mon, Jun 14, 2021
[Archive]
Volume 5, Issue 2 (Spring 2020)
J Obstet Gynecol Cancer Res 2020, 5(2): 61-67 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaei Z, Taghdisi S. A Comparison of Fertility Rates in Women Undergoing IVF with a Tubal Factor with Surgery, Tubal Factor Infertility Without Surgery, and Unexplained Infertility. J Obstet Gynecol Cancer Res. 2020; 5 (2) :61-67
URL: http://jogcr.com/article-1-274-en.html
URL: http://jogcr.com/article-1-274-en.html
1- Tehran University of Medical Sciences, Yas Hospital, Tehran, Iran
2- North Khorasan University of Medical Sciences, Bint Al-Huda Hospital, Bojnurd, Iran Iran , s.taghdisi@nkums.ac.ir
2- North Khorasan University of Medical Sciences, Bint Al-Huda Hospital, Bojnurd, Iran Iran , s.taghdisi@nkums.ac.ir
Abstract: (4938 Views)
Background & Objective: Many factors are essential for a pregnancy to be successful. Recognizing the factors caused by surgical trauma may be effective in guiding pregnancies toward success using the assisted reproductive treatment methods. Surgery changes the natural anatomical relation between the ovaries and fallopian tubes. Tubal surgery is hypothesized to reduce ovarian reserve due to the anatomical relationship between the ovarian arteries and nerves and fallopian tubes. There is no consensus on whether or not salpingectomy affects ovarian reserve. Some authors believe that salpingectomy has no effects, while others suggest that it diminishes ovarian reserve. Therefore, comparing fertility rates between women undergoing in vitro fertilization with tubal factor infertility with surgery, tubal factor infertility without surgery, and unexplained infertility can provide valuable data.
Materials & Methods: Eighty patients who met the inclusion criteria were studied. Study groups included people with a history of tubal surgery, individuals who had tubal problems without a history of surgery, and cases with unexplained infertility. Anti-Mullerian hormone (AMH) was measured every day of the cycle and other hormones, including follicle-stimulating hormone (FSH), luteinizing hormone, prolactin, and thyroid-stimulating hormone (TSH) were assessed on days 2-5 of the cycle. On the third day of the menstrual cycle, the uterus, endometrial thickness, ovaries, the size of the ovaries, and antral follicle count were evaluated using transvaginal sonography. Following ovulation induction, treatment-related factors, namely endometrial thickness, gonadotropin (Gn) time and count, E2, viable embryos, and good quality embryos, were examined.
Results: Our findings showed no difference between the study groups in terms of treatment-related factors. No significant correlation was observed between the studied groups and chemical pregnancy (P=0.9514). moreover, the studied groups were not significantly correlated with clinical pregnancy (P=0.5052).
Conclusion: The AMH was correlated with FSH, AFC, E2, and gonadotropin time and count. According to the results of the present study, tubal surgery does not affect the outcome of assisted reproductive cycles.
Systematic Review: Original Research |
Subject:
Obstetrics and Gynecology
Received: 2020/08/21 | Accepted: 2020/09/13 | Published: 2020/10/28
Received: 2020/08/21 | Accepted: 2020/09/13 | Published: 2020/10/28
References
1. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. lippincott Williams & wilkins; 2012 Mar 28.
2. Celik HG, Dogan E, Okyay E, Ulukus C, Saatli B, Uysal S, Koyuncuoglu M. Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels. Fertil Steril. 2012;97(6):1472-8. [DOI:10.1016/j.fertnstert.2012.03.027] [PMID]
3. Rock JA, Jones HW, Te Linde RW, Wesley R. Te Linde S operative gynecology. Wolters Kluwer Health/Lippincott Williams & Wilkins,; 2008.
4. da Silva AL, da Ré C, Dietrich C, Fuhrmeister IP, Pimentel A, Corleta HV. Impact of tubal ligation on ovarian reserve as measured by anti-Müllerian hormone levels: a prospective cohort study. Contraception. 2013;88(6):700-5. [DOI:10.1016/j.contraception.2012.09.021] [PMID]
5. Tal J, Paltieli Y, Korobotchka R, Ziskind G, Eibschitz I, Ohel G. Ovarian response to gonadotropin stimulation in repeated IVF cycles after unilateral salpingectomy. Journal of assisted reproduction and genetics. 2002;19(10):451-5. [DOI:10.1023/A:1020302301326] [PMID] [PMCID]
6. Lin YJ, Ou YC, Huang FJ, Lin PY, Kung FT, Lan KC. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy. J Minim Invasive Gynecol. 2013;20(5):637-41. [DOI:10.1016/j.jmig.2013.04.005] [PMID]
7. Dar P, Sachs GS, Strassburger D, Bukovsky I, Arieli S. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod. 2000;15(1):142-4. [DOI:10.1093/humrep/15.1.142] [PMID]
8. Olug P. Evaluation of the effects or single or multiple dose methotrexate administration, salpingectomy on ovarian reserve of rat with the measurement of anti-Mullerian hormone (AMH) levels and histological analysis. Eur J Obstet Gynecol Reprod Biol. 2014(181):205-9. [DOI:10.1016/j.ejogrb.2014.07.011] [PMID]
9. Ye XP, Yang YZ, Sun XX. A retrospective analysis of the effect of salpingectomy on serum antiMüllerian hormone level and ovarian reserve. Am J Obstet Gynecol. 2015;212(1):53-e1. [DOI:10.1016/j.ajog.2014.07.027] [PMID]
10. Grynnerup AG, Lindhard A, Sørensen S. Anti‐Müllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility. Acta Obstet Gynecol Scand. 2013;92(11):1297-303. [DOI:10.1111/aogs.12234] [PMID]
11. Weenen C, Laven JS, von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti‐Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77-83. [DOI:10.1093/molehr/gah015] [PMID]
12. Hudson Pl, Dougas I, Donahoe Pk, Cate Rl, Epstein J, Pepinsky Rb, Maclaughlin Dt. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab. 1990;70(1):16-22. [DOI:10.1210/jcem-70-1-16] [PMID]
13. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002 ;77(2):357-62. [DOI:10.1016/S0015-0282(01)02993-4]
14. Cook CL, Siow Y, Taylor S, Fallat ME. Serum müllerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril. 2000;73(4):859-61. [DOI:10.1016/S0015-0282(99)00639-1]
15. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91(10):4057-63. [DOI:10.1210/jc.2006-0331] [PMID]
16. Van Rooij IA, Broekmans FJ, Te Velde ER, Fauser BC, Bancsi LF, De Jong FH, Themmen AP. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. 17. Hum Reprod Update. 2002;17(12):3065-71. [DOI:10.1093/humrep/17.12.3065] [PMID]
17. van Rooij IA, den Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause. 2004;11(6 Part 1 of 2):601-6. [DOI:10.1097/01.GME.0000123642.76105.6E] [PMID]
18. Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol. 2011;118(6):1271. [DOI:10.1097/AOG.0b013e318236fd12] [PMID] [PMCID]
19. Sezik M, Ozkaya O, Demir F, Sezik HT, Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. 20. J Obstet Gynaecol Res. 2007;33(6):863-9. [DOI:10.1111/j.1447-0756.2007.00669.x] [PMID]
20. Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, Reekers JA, Ankum WM. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007 ;22(7):1996-2005. [DOI:10.1093/humrep/dem105] [PMID]
21. Abdelazim IA, Abdelrazak KM, Elbiaa AA, Farghali MM, Essam A, Zhurabekova G. Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy. Prz Menopauzalny. 2015;14(4):238. [DOI:10.5114/pm.2015.56312] [PMID] [PMCID]
22. Ercan CM, Sakinci M, Coksuer H, Keskin U, Tapan S, Ergun A. Ovarian reserve testing before and after laparoscopic tubal bipolar electrodesiccation and transection. Eur J Obstet Gynecol Reprod Biol. 2013;166(1):56-60. [DOI:10.1016/j.ejogrb.2012.09.013] [PMID]
23. Findley AD, Siedhoff MT, Hobbs KA, Steege JF, Carey ET, McCall CA, Steiner AZ. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril. 2013;100(6):1704-8. [DOI:10.1016/j.fertnstert.2013.07.1997] [PMID] [PMCID]
24. Goynumer G, Kayabasoglu F, Aydogdu S, Wetherilt L. The effect of tubal sterilization through electrocoagulation on the ovarian reserve. Contraception. 2009;80(1):90-4. [DOI:10.1016/j.contraception.2008.12.012] [PMID]
25. Kelekci S, Yilmaz B, Yakut Y, Yasar L, Savan K, Sonmez S. Hormonal and ovarian stromal blood supply changes after laparoscopic tubal sterilization: a prospective controlled study. Contraception. 2006;73(3):279-83. [DOI:10.1016/j.contraception.2005.08.001] [PMID]
26. Kaya C, Turgut H, Cengiz H, Turan A, Ekin M, Yaşar L. The effect of tubal sterilization with the Pomeroy technique and bipolar electrocauterization on the ovarian reserve and serum anti-Müllerian hormone levels in a rat model. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;185:108-13. [DOI:10.1016/j.ejogrb.2014.12.005] [PMID]
27. Morelli M, Venturella R, Mocciaro R, Di Cello A, Rania E, Lico D, D'Alessandro P, Zullo F. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol. 2013;129(3):448-51. [DOI:10.1016/j.ygyno.2013.03.023] [PMID]
28. Lass A, Ellenbogen A, Croucher C, Trew G, Margara R, Becattini C, Winston RM. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil Steril. 1998;70(6):1035-8. [DOI:10.1016/S0015-0282(98)00357-4]
29. Venturella R, Morelli M, Lico D, Di Cello A, Rocca M, Sacchinelli A, Mocciaro R, D'Alessandro P, Maiorana A, Gizzo S, Zullo F. Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial. Fertil Steril. 2015;104(5):1332-9. [DOI:10.1016/j.fertnstert.2015.08.004] [PMID]
30. Ahn EH, Bai SW, Song CH, Kim JY, Jeong KA, Kim SK, Lee JS, Kwon JY, Park KH. Effect of hysterectomy on conserved ovarian function.
31. Ni L, Sadiq S, Mao Y, Cui Y, Wang W, Liu J. Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment. Gynecol Endocrinol. 2013 Apr 1;29(4):345-9. [DOI:10.3109/09513590.2012.743004] [PMID]
32. Mocciaro R, Venturella R, Morelli M, Zullo F. Ovarian Function after Anterograde or Retrograde Salpingectomy. J Minim Invasive Gynecol. 2012;19(6):S47. [DOI:10.1016/j.jmig.2012.08.144]
33. Carmona F, Cristóbal P, Casamitjana R, Balasch J. Effect of tubal sterilization on ovarian follicular reserve and function. Am J Obstet Gynecol. 2003 Aug 1;189(2):447-52. [DOI:10.1067/S0002-9378(03)00487-3]
34. Toyganözü H, Nazik H, Narin R, Satar D, Narin MA, Büyüknacar S, et al. Examination of the Ovarian Reserve after Generation of Unilateral Rudimentary Uterine Horns in Rats. Sci World J. 2014;2014:1-5. [DOI:10.1155/2014/918496] [PMID] [PMCID]
35. Mohamed AA, Yosef AH, James C, Al‐Hussaini TK, Bedaiwy MA, Amer SA. Ovarian reserve after salpingectomy: a systematic review and meta‐analysis.Acta Obstet Gynecol Scand. 2017;96(7):795-803. [DOI:10.1111/aogs.13133] [PMID]
36. Tehranian A, Zangbar RH, Aghajani F, Sepidarkish M, Rafiei S, Esfidani T. Effects of salpingectomy during abdominal hysterectomy on ovarian reserve: a randomized controlled trial. Gynecol Surg. 2017;14(1):17. [DOI:10.1186/s10397-017-1019-z] [PMID] [PMCID]
37. Qin F, Du DF, Li XL. The effect of salpingectomy on ovarian reserve and ovarian function. Obstet Gynecol Surv. 2016;71(6):369-76. [DOI:10.1097/OGX.0000000000000323] [PMID]
38. Yoon SH, Lee JY, Kim SN, Chung HW, Park SY, Lee C. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?. Fertil Steril. 2016 ;106(5):1083-92. [DOI:10.1016/j.fertnstert.2016.05.030] [PMID]
Send email to the article author
Copyright Policy
Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://jogcr.com/.
